drugset / Trial / NCT02940418
Use of Stem Cells in Diabetes Mellitus Type 1
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Allogenic adipose derived mesenchymal stem cells will be injected into patients newly diagnosed with type 1 Diabetes Mellitus
Timeline
- Start
- 2017-02-19
- Primary completion
- 2019-11
- Completion
- 2020-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | bone marrow mononuclear cells | Cell therapy | 1e+06 cells/kg | Intravenous |
| Comparator | bone marrow mononuclear cells | Cell therapy | 1e+07 cells/kg | Intravenous |
| Comparator | Adipose-derived mesenchymal cells | Cell therapy | — | Intravenous |